Related Experiment Video

Updated: May 22, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

242

Tumor Glycosylation: A Main Player in the Modulation of Immune Responses

Ernesto Rodriguez1,2,3

  • 1Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, Amsterdam, The Netherlands.

European Journal of Immunology
|March 12, 2025
PubMed

Insights

Cancer cells evade the immune system through altered glycosylation, impacting immune responses. Understanding these tumor glycosylation changes is key to developing new cancer therapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Glycobiology

Background:

  • Tumor immune escape allows cancer cells to evade immune detection and destruction.
  • Aberrant glycosylation is a common hallmark of cancer, significantly influencing the tumor microenvironment.
  • Specific glycosylation patterns modulate immune cell interactions and responses.

Purpose of the Study:

  • To review the role of aberrant tumor glycosylation in promoting immune tolerance.
  • To highlight key glycosylation signatures (fucosylation, truncated O-glycans, sialylation) and their associated immune receptors.
  • To discuss the clinical significance and therapeutic potential of targeting tumor glycosylation.

Main Methods:

  • Literature review of current research on tumor glycosylation and immune escape.
  • Analysis of specific glycosylation patterns and their impact on immune recognition.
  • Examination of clinical data and therapeutic strategies related to tumor glycosylation.

Main Results:

  • Aberrant tumor glycosylation creates a tolerogenic microenvironment, hindering anti-tumor immunity.
  • Specific modifications like fucosylation, truncated O-glycans, and sialylation are critical mediators of immune evasion.
  • Immune receptors interacting with these glycans play a vital role in modulating the immune response.

Conclusions:

  • Targeting aberrant tumor glycosylation offers a promising strategy to enhance anti-cancer immunity.
  • Further research into glycosylation signatures and immune receptor interactions is crucial for developing effective cancer immunotherapies.
  • Understanding tumor glycosylation is essential for overcoming immune escape and improving cancer treatment outcomes.
Keywords:
cancerglycosylationglyco‐codelectin receptors

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.4K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.3K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
6.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K